Apoptosis of glioma cells induced by the fibroblast growth factor inhibitor 1,3,6-naphthalenetrisulfonate

Neuroscience Letters

Volumn 275, Issue 2, 1999, Pages 149-151

  Cuevas, Pedro ^a   Reimers, Diana ^a   Diaz, Diana ^a   Lozano, Rosa M ^b   Giménez Gallego, Guillermo ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b CSIC   (Spain)

Author keywords

Apoptosis; Fibroblast growth factor inhibition; Glioma; Terminal dUTP nick end labeling assay

Indexed keywords

1,3,6 NAPHTHALENETRISULFONATE; ANTINEOPLASTIC AGENT; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; GLIOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; FIBROBLAST GROWTH FACTORS; GLIOMA; IN SITU NICK-END LABELING; NAPHTHALENESULFONATES; RATS; TUMOR CELLS, CULTURED;

EID: 0032742656     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00752-1     Document Type: Article

References (22)

1. Araki S., Shimada Y., Kaji K., Hayashi H. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem. Biophys. Res. Commun. 168:1990;1194-1200.
2. Bjerkvig R., Lund-Johansen M., Edvardsen K. Tumor cell invasion and angiogenesis in the central nervous system. Curr. Opin. Oncol. 9:1997;223-229.
3. Cuevas P., Carceller F., Reimers D., Saenz de Tejada I., Giménez-Gallego G. Acidic fibroblast growth factor rescues gerbil hippocampal neurons from ischemic apoptotic death. Neurol. Res. 20:1998;271-274.
4. Cuevas P., Lozano R.M., Giménez-Gallego G. Suppression of acidic fibroblast growth factor-dependent angiogenesis by the antigrowth activity of 1,3,6-naphthalenetrisulfonate. Neurol. Res. 21:1999;191-194.
5. Cuevas P., Carceller F., Reimers D., Cuevas B., Lozano R.M., Giménez-Gallego G. Inhibition of intratumoral angiogenesis and glioma growth by the fibroblast growth factor inhibitor, 1,3,6-naphthalenetrisulfonate. Neurol. Res. 21:1999;481-487.
6. Denekamp J. Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br. J. Radiol. 66:1993;181-196.
7. Evan G., Littlewood T. A matter of life and cell death. Science. 281:1998;1317-1322.
8. Folkman J. The role of angiogenesis in tumor growth. Semin. Cancer Biol. 3:1992;65-71.
9. Gavrieli Y., Sherman Y., Ven-Sasson S.A. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
10. Jäättle M. Escaping cell death: survival proteins in cancer. Exp. Cell Res. 248:1999;30-43.
11. Kondo S., Yin D., Aoki T., Takahashi J.A., Morimura T., Takeuchi J. bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endothelial cells. Exp. Cell Res. 213:1994;428-432.
12. Krajewski S., Blomqvist C., Fransila K., Krajewska M., Wasenins V.M., Niskanen E., Norling S., Reed J.C. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 55:1995;4471-4478.
13. Lozano R.M., Jiménez M.A., Santoro J., Rico M., Giménez-Gallego G. Solution structure of acidic fibroblast growth factor bound to 1,3,6-naphthalenetrisulfonate. A minimal model for the anti-tumoral action of suramins and sudaristas. J. Mol. Biol. 281:1998;899-915.
14. Pedersen P.H., New G.O., Engebreaten O., Bjerkvig R., Lillehang J.R., Laerum O.D. Heterogenous response to the growth factors (EGF, PDGF(bb), TGF-α, bFGF, IL-2) on glioma spheroid growth, migration and invasion. Int. J. Cancer. 56:1994;255-261.
15. Harima Y., Harima K., Shikata N., Oka A., Ohnishi T., Tanaka Y. Bax and Bcl-2 expressions predict response to radiotherapy in human cervical cancer. J. Cancer Res. Clin. Oncol. 124:1998;503-510.
16. Stan A.C., Nemati M.N., Pietsch T., Walter G.F., Dietz H. In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumor by treatment with an antibody against basic fibroblast growth factor. J. Neurosurg. 82:1995;1044-1052.
17. Stefanik D.F., Rizkalla L.R., Soi A., Goldblatt S.A., Rizkalla W.M. Acidic and basic fibroblast growth factors are present in glioblastoma multiforme. Cancer Res. 51:1991;5760-5765.
18. Takahashi J.A., Fukumoto M., Kozai Y., Ito N., Oda Y., Kikuchi H., Hatanaka M. Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human fibroblast growth factor. FEBS Lett. 288:1991;65-71.
19. Wang Y., Becker D. Antisense targeting of basic fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat. Med. 8:1997;887-893.
20. Webb S.J., Harrison D.J., Wyllie A.H. Apoptosis: an overview of the process and its relevance in disease. Kaufmann S.T. Advances in Pharmacology: Apoptosis. Pharmacological Implications and Therapeutics Opportunities, Vol. 41. 1997;1-34 Academic Press, San Diego, CA.
21. Wyllie A.H. Apoptosis. Br. J. Cancer. 67:1993;205-208.
22. Wright J.A., Huang A. Growth factors in mechanisms of malignancy: roles of TGF-beta and FGF. Histol. Histopathol. 11:1996;521-536.